Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.

Autor: Rubio-Muniz CA; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sánchez-Velázquez A; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain., Arroyo-Andrés J; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain., Agud-de Dios M; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain., Tarín-Vicente EJ; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain., Falkenhain-López D; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain., Ortiz-Romero PL; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Institute i+12 CIBERONC, Medical School, University Complutense, Madrid, Spain.
Jazyk: angličtina
Zdroj: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jan; Vol. 38 (1), pp. e102-e105. Date of Electronic Publication: 2023 Aug 31.
DOI: 10.1111/jdv.19457
Databáze: MEDLINE
Externí odkaz: